CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance cancer immunotherapy by developing personalized treatments based on individual tumor mutations and advanced bioconjugation technologies. By combining expertise in biotechnology, the project seeks to create effective biotherapeutics tailored to the unique characteristics of each patient's ca…
Immunotherapy for cancer has recently shown great clinical potential.
However, only small percentages of patients do benefit from these therapies.
The dual objective of the proposal is to understand and harness the immune system in vivo to develop truly personalized (individualized) anti-cancer treatments and to develop powerful bioconjugation technologies to generate new and better biotherapeutics.
The project objectives will be achieved through the combination of ProteoDesign’s site-specific b…
PROTEODESIGN SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
